“…This observation is perhaps unsurprising, considering that the very concept of privileged structures was coined in a Merck publication devoted to benzodiazepines. That such an ambitious goal can, in principle, be realized has already been elegantly demonstrated by the "intramolecular" Ugi reaction of benzene-tethered oxocarboxylic acids; this delivered tetrahydro versions of benzo[c]azepines, [16] benzo[f ] [1,4]thiazepines, [17] benzo[f ] [1,4]oxazepines, [18] and benzo[e] [1,4]diazepines [19] (i.e., all four of the scaffolds shown in Figure 1). That such an ambitious goal can, in principle, be realized has already been elegantly demonstrated by the "intramolecular" Ugi reaction of benzene-tethered oxocarboxylic acids; this delivered tetrahydro versions of benzo[c]azepines, [16] benzo[f ] [1,4]thiazepines, [17] benzo[f ] [1,4]oxazepines, [18] and benzo[e] [1,4]diazepines [19] (i.e., all four of the scaffolds shown in Figure 1).…”